EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Meropenem and fosfomycin against Klebsiella pneumoniae: Towards a combination breakpoint using a pharmacometric approach

Aneeq Farooq, Miklas Martens, Marie L G Attwood, Patrice Nordmann, Alasdair MacGowan, Sebastian G Wicha

Clinical Microbiology and Infection · 2026

DOI: 10.1016/j.cmi.2026.02.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2026. Verfasst von Aneeq Farooq und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany. Hauptthemen laut MEDLINE: Fosfomycin, Klebsiella pneumoniae, Anti-Bacterial Agents, Thienamycins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: InfectoPharm, BMBF Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FosfomycinKlebsiella pneumoniaeAnti-Bacterial AgentsThienamycinsMeropenemMicrobial Sensitivity TestsHumansDrug Resistance, Multiple, BacterialKlebsiella Infections

Stichwörter der Autor:innen

BreakpointFosfomycinK. pneumoniaeMeropenemPK/PDPharmacometricsSynergy

Substanzen

FosfomycinMeropenemAnti-Bacterial AgentsThienamycins

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.
  • Bristol Centre for Antimicrobial Research and Evaluation (BCARE), Antimicrobial Reference Laboratory, Infection Sciences, Southmead Hospital, Bristol, UK.
  • Medical and Molecular Microbiology, University of Fribourg, Fribourg, Switzerland.
  • Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany. Electronic address: sebastian.wicha@uni-hamburg.de.

Förderung

  • InfectoPharm
  • BMBF Bonn

Zitieren

APA

Farooq, A., Martens, M., Attwood, M. L. G., Nordmann, P., MacGowan, A., & Wicha, S. G. (2026). Meropenem and fosfomycin against Klebsiella pneumoniae: Towards a combination breakpoint using a pharmacometric approach. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.02.024

Vancouver

Farooq A, Martens M, Attwood MLG, Nordmann P, MacGowan A, Wicha SG. Meropenem and fosfomycin against Klebsiella pneumoniae: Towards a combination breakpoint using a pharmacometric approach. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2026.02.024

BibTeX
@article{Farooq2026,
  author = {Farooq, Aneeq and Martens, Miklas and Attwood, Marie L G and Nordmann, Patrice and MacGowan, Alasdair and Wicha, Sebastian G},
  title = {Meropenem and fosfomycin against Klebsiella pneumoniae: Towards a combination breakpoint using a pharmacometric approach},
  journal = {Clinical Microbiology and Infection},
  year = {2026},
  doi = {10.1016/j.cmi.2026.02.024}
}
Kostenlos starten →